nyse

Новости были примерно такие:
 

SPY — растет непрерывно с 18:00мск
EBAY — гэпанул и встал на месте. Пара раз был шортокрыл резкий
BWA — шорт дня, валится безоткатно
MCD — раздали вчерашний левый вынос, стак выставился в полку на 95.5
IRM — полка 32.70. Вчера взлетели на левом слухе, сегодня тупо встали. покупки нет. Судя по всему пойдет вниз
CSC — наверна будет еще расти, смотрим на нее
CTAS — суператренд дня. Хз как в такое входить
FDX — хаи везде. Техника + новости на бай
 

Ближайший уровень поддержки по SPY – 197.50 уровень сопротивления – 198.25



CLVS продажа от 49

CSC смотрим на продажу

AMBA покупка выше 44.50

ETP смотрим на продолжение роста

CVEO покупка от 13

Gapping up/down: WAG +2% after earnings, MOVE +37% after merger news, TASR +4% on London Police camera news, AA +1% on upgrade; DWA -9% on downplay of takeover chatter, miners trading lower, CRR -1% on dg Price: null Change: null 

Gapping up 
In reaction to strong earnings/guidance: SNX +8.1%, (also initiates quarterly cash dividend of $0.125 per common share), SCOK +7.7%, WAG +2.3%, RBS +2.1%, CTAS +1.1%, HTGC +0.8%, (on track to achieve annual new commitments of approximately $700-$850 million for 2014)

M&A news: MOVE +37% (to be acquired by News Corp (NWSA) for $21 per share), DLIA +25% (announces review of strategic alternatives; received several inquiries from third parties regarding potential acquisition of the company), MAS +7.2% (announces strategic initiatives; Co to spin-off installation and other services segment, initiate share repurchase program and reduce corporate expense), SMPL +4.9% (HomeStreet to merge with Simplicity Bancorp; Simplicity stockholders to receive one share of HomeStreet common stock for each share of Simplicity common stock)

Other news: WYY +17.8% (received two new Task Orders from federal agencies under a recently awarded Federal Government Blanket Purchase Agreement), VIMC +13.8% (announces $12.4 mln contract win in Taiyuan City of Shanxi Province), CPRX +13.7% (announces positive top-line Phase 3 Data From Pivotal Firdapse clinical trial in patients with Lambert-Eaton Myasthenic Syndrome), ACST +11.5% (announces 'Positive' top-line Pharmacokinetic results), CRNT +10.8% (receives follow-on orders from a global Tier 1 operator serving 20 countries across Asia and Africa), CANF +9.6% (USPTO issues Can-Fite patent for CF102 in the treatment of liver regeneration and function following surgery), EBAY +8.9% (eBay to separate eBay and PayPal into independent publicly traded companies in 2015), BLDP +8.2% (receives ElectraGen fuel cell system order for deployments in Digicel network), CNET +7.8% (Co's Liansuo.com signs 12 new clients following Guangzhou Franchise Exhibition), HTZ +5.4% (still checking), TASR +3.9% (selected by the London Metropolitan Police Service to provide another 500 AXON cameras), PLUG +3.4% (move attributed to positive blog mention, also peer BLDP received large order), RWLK +2.9% (cont momentum post IPO), MCP +2.4% (announces that its expanded leach system has now been placed into service at its Mountain Pass, California Facility), CTRP +2.3% (Priceline (PCLN) disclosed a 5.84% active stake in 13D filing) MBLY +2.3% (still checking), RADA +2.2% (following yesterday's 35% move higher), GPRO +1.9% (following 11% upside move yesterday), HIMX +1.8% (cont momentum), EXXI +1.5% (provides operations update: Q1 production expected at mid-point of guidance; West Delta horizontal program continues to deliver with three new wells brought online ), Z +1.4% (MOVE peer), KR +1.2% (positive commentary on Monday's Mad Money), SDRL +1.1% (still checking, may be just bouncing — shares have sold off significantly in recent weeks), AAPL +0.8% (iPhone 6 & iPhone 6 Plus available in China on Friday, October 17)

( Читать дальше )

Всем привет! Некоторые акции на сегодня:
Акция RGDO наблюдаю уровень 1,25 по пробитию уровня сопротивления, буду данную акцию рассматривать на лонг.



( Читать дальше )

Ходят слухи, что Айкан покупает акции MCD. А может это Баффет на самом деле?


 

Ближайший уровень поддержки по SPY – 196.75 уровень сопротивления – 197.25



AGIO продажа ниже 64

NKE продажа от 89

LLL продажа от 114.75

IRM покупка выше 32

Gapping up/down: AMBI +88%, DWA +26%, ATHL +24%, TIBX +21% and AMAG +15% on M&A related news; HIMX +2% on upgrade; EU financials, select energy and metal names trading lower; AVY -1% on dg at JPM Price: null Change: null 

Gapping up 
In reaction to strong earnings/guidance: RCON +7.2%, LAS +2.3%, KOOL +1.7%, CALM +1.2%, ADP +0.7%

M&A news: AMBI +87.8% (Daiichi Sankyo (DSNKY) to acquire Ambit Biosciences for $15 per share in cash through a tender offer), DWA +26.4% (Softbank (SFTBY) is in discussions to purchase DWA, according to reports, Variety discusses comments from sources that chances of Softbank (SFTBY) acquiring DWA are slim), ATHL +24.6% (Encana (ECA) to acquire all of the issued and outstanding shares of common stock of Athlon by means of an all-cash tender offer for $58.50 per share), TIBX +21% (to be acquired by Vista Equity Partners for $24.00 per share in cash), AMAG +15.4% (to acquire Lumara Health for $600 mln in cash and $75 mln in stock and additional contingent consideration of up to $350 mln)

Other news: EXEL +18.6% (announces positive results from Phase 3 pivotal trial of Cobimetinib in combination with Vemurafenib in patients with BRAF V600 Mutation-positive advanced melanoma), ALIM +16.6% (provides details on FDA approval Of ILUVIEN as the first long-term treatment for diabetic macular edema), ECYT +10.2% (Phase 2b TARGET trial results show improved survival in Adenocarcinoma non-small cell lung cancer patients treated with Endocyte's Vintafolide), PSDV +9.8% (reports approval of ILUVIEN for diabetic macular edema; triggers $25 mln milestone payment from Alimera Sciences (ALIM)), CYTR +7.9% (receives multiple FDA Orphan Drug designations for Aldoxorubicin for the treatment of Glioblastoma), PE +5.6% (still checking), ACST +4.1% (reports successful CaPre Phase II TRIFECTA results proving statistically significant improvements in triglycerides & non-HDL-C), ARIA +4% (announces updated clinical results for AP26113, study results show sustained anti-tumor activity), SGEN +3.9% (Seattle Genetics and Takeda (TKPYY) announce positive data from Phase 3 AETHERA clinical trial of ADCETRIS), KMDA +3.3% (announces second extension of Strategic Agreement with Baxter (BAX)), ISR +3.1% (still checking), DATE +3% (declared a special one-time cash dividend of $0.4467 per ordinary share, or $0.67 per American Depositary Share), WEX +1.4% (positive commentary on Friday's Mad Money)

( Читать дальше )

скриншот: 
 

дешман ниже $20 не берем

что упустил? 

DWA. ATHL — поглощение
ECA — покупает ATHL
 

Finderby.net продолжает серию бесплатных турниров среди трейдеров!

Всего через 3,5 часа (в 20-00 по МСК) начнется FREEROLL 500 на NYSE с призовым фондом 500$.

И завтра в 19-00 по Московскому времени стоится Freeroll 300 на FORTS.



Регистрируйтесь сейчас в оба турнира, покажите на что способны за время турнира и заберите свой приз!
Это просто, быстро и весело!

 

Ключевой показатель Вашего портфеля ценных бумаг и валюты – диверсификация.

Для определения своего места по этой шкале Вам понадобится измерить доходность своего портфеля и её стандартное отклонение. Интересно как?

Диверсификация портфеля

Диверсификация портфеля — это когда Вы раскладываете его по многим странам, отраслям и ценным бумагам. Проводится обычно с целью минимизации риска, когда нет ни кризиса экономики, ни существенного роста отдельных ценных бумаг.

Причиной существенной диверсификации портфеля может быть падение рынка к минимумам. Если нет потребности в коротких позициях и понимания, какая акция выстрелит и взлетит в небеса, можно просто диверсифицироваться. Такая тактика будет работать до тех пор, пока не настанет следующий кризис.

( Читать дальше )